These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15811457)

  • 1. Does DOTS work in populations with drug-resistant tuberculosis?
    DeRiemer K; García-García L; Bobadilla-del-Valle M; Palacios-Martínez M; Martínez-Gamboa A; Small PM; Sifuentes-Osornio J; Ponce-de-León A
    Lancet; 2005 Apr 2-8; 365(9466):1239-45. PubMed ID: 15811457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
    Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
    Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug resistance of Mycobacterium tuberculosis in Orizaba, Veracruz. Implications for the tuberculosis prevention and control program].
    García-García ML; Sifuentes-Osornio J; Jiménez-Corona ME; Ponce-de-León A; Jiménez-Corona A; Bobadilla-del Valle M; Palacios-Martínez M; Canales G; Sanginés A; Jaramillo Y; Martínez-Gamboa A; Balandrano S; Valdespino-Gómez JL; Small P
    Rev Invest Clin; 2001; 53(4):315-23. PubMed ID: 11599478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan.
    Chien JY; Lai CC; Tan CK; Chien ST; Yu CJ; Hsueh PR
    J Antimicrob Chemother; 2013 Aug; 68(8):1910-6. PubMed ID: 23580558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of drug resistant tuberculosis among patients at high-risk for Hiv attending outpatient clinics in Delhi, India.
    Magee MJ; Blumberg HM; Broz D; Furner SE; Samson L; Singh S; Hershow RC
    Southeast Asian J Trop Med Public Health; 2012 Mar; 43(2):354-63. PubMed ID: 23082587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of drug resistance under the DOTS strategy in Hyderabad, South India, 2001-2003.
    Anuradha B; Aparna S; Hari Sai Priya V; Vijaya Lakshmi V; Akbar Y; Suman Latha G; Murthy KJ
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):58-62. PubMed ID: 16466038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial drug resistance pattern among pulmonary tuberculosis patients.
    Gupta H; Kant S; Jain A; Natu SM; Ahluwalia S
    Indian J Tuberc; 2013 Jul; 60(3):154-61. PubMed ID: 24000493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
    Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H
    Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of treating multidrug-resistant tuberculosis.
    Resch SC; Salomon JA; Murray M; Weinstein MC
    PLoS Med; 2006 Jul; 3(7):e241. PubMed ID: 16796403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium tuberculosis drug resistance in a suburban community in southern Mexico.
    García-García ML; Jiménez-Corona ME; Ponce-de-León A; Jiménez-Corona A; Palacios-Martínez M; Balandrano-Campos S; Ferreyra-Reyes L; Juárez-Sandino L; Sifuentes-Osornio J; Olivera-Díaz H; Valdespino-Gómez JL; Small PM
    Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S168-70. PubMed ID: 11144548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug resistant tuberculosis].
    Zwolska Z; Augustynowicz-Kopeć E
    Pol Merkur Lekarski; 2011 May; 30(179):362-6. PubMed ID: 21675144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Health.
    Telzak EE; Chirgwin KD; Nelson ET; Matts JP; Sepkowitz KA; Benson CA; Perlman DC; El-Sadr WM
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):337-43. PubMed ID: 10206505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.
    Ormerod LP
    Br Med Bull; 2005; 73-74():17-24. PubMed ID: 15956357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug susceptibility pattern of Mycobacterium tuberculosis isolates from patients of category-II failure of pulmonary tuberculosis under directly observed treatment short-course from north India.
    Prasad R; Verma SK; Garg R; Jain A; Anand SC; Hosmane GB; Verma RK; Kushwaha NS; Kant S
    Biosci Trends; 2012 Jun; 6(3):110-4. PubMed ID: 22890158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of multidrug-resistant pulmonary tuberculosis in counties with different duration of DOTS implementation in rural China.
    Hu Y; Mathema B; Wang W; Hoffner S; Kreiswirth B; Xu B
    Microb Drug Resist; 2008 Sep; 14(3):227-32. PubMed ID: 18707239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis in Europe: a problem of drug resistance or much more?
    Carvalho AC; Migliori GB; Cirillo DM
    Expert Rev Respir Med; 2010 Apr; 4(2):189-200. PubMed ID: 20406085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-resistant pulmonary tuberculosis in Los Altos, Selva and Norte regions, Chiapas, Mexico.
    Sánchez-Pérez HJ; Díaz-Vázquez A; Nájera-Ortiz JC; Balandrano S; Martín-Mateo M
    Int J Tuberc Lung Dis; 2010 Jan; 14(1):34-9. PubMed ID: 20003692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a standardised regimen for multidrug-resistant tuberculosis in Bangladesh.
    Van Deun A; Salim MA; Das AP; Bastian I; Portaels F
    Int J Tuberc Lung Dis; 2004 May; 8(5):560-7. PubMed ID: 15137531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis drug resistance and treatment outcomes under DOTS settings in large cities in the Philippines.
    Ohkado A; Aguiman L; Adlawan S; Baring E; Quirante O; Suchi M; Endo S; Fujiki A; Mori T
    Int J Tuberc Lung Dis; 2006 Mar; 10(3):283-9. PubMed ID: 16562708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.